Elevation of vascular endothelial growth factor A serum levels following acute myocardial infarction. Evidence for its origin and functional significance

Journal of Molecular and Cellular Cardiology

Volumn 32, Issue 1, 2000, Pages 65-72

  Kranz, Andrea ^a   Rau, Christoph ^a   Kochs, Matthias ^a   Waltenberger, Johannes ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Angiogenesis; Arteriogenesis; Collateral circulation; Endothelial function; Myocardial infarction; Platelets; VEGF

Indexed keywords

VASCULOTROPIN;

ACUTE HEART INFARCTION; ADULT; ANGIOGENESIS; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CORONARY SINUS; FEMALE; HEART MUSCLE INJURY; HUMAN; HUMAN CELL; IMMUNORADIOMETRIC ASSAY; MALE; PRIORITY JOURNAL; UNSTABLE ANGINA PECTORIS;

ANGINA;

EID: 0033971166     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1999.1062     Document Type: Article

References (41)

1. Sasayama S, Fujita M. Recent insights into coronary collateral circulation. Circulation. 85:1992;1197-1204.
2. Sabia PJ, Powers ER, Ragosta M, Sarembock IJ, Burwell LR, Kaul S. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med. 327:1992;1825-1831.
3. Schaper W, Ito WD. Molecular mechanisms of coronary collateral vessel growth. Circ Res. 79:1996;911-919.
4. Waltenberger J. Modulation of growth factor action. Clinical implications for the treatment of vascular disease. Circulation. 96:1997;4083-4094.
5. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 359:1992;843-845.
6. Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, Simons M. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol. 270:1996;H1803-H1811.
7. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, Keshet E. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res. 28:1994;1176-1179.
8. Waltenberger J. Therapeutic angiogenesis in the heart using peptide growth factors: angiogenesis research entering clinical trials. Angiogenesis. 2:1998;115-117.
9. Baker PN, Krasnow J, Roberts JM, Yeo K. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol. 86:1995;815-821.
10. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 331:1994;1480-1487.
11. Salven P, Teerenhovi L, Joensuu H. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood. 90:1997;3167-3172.
12. Takano S, Yoshii Y, Kondo H, Maruno T, Shirai S, Nose T. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res. 56:1996;2185-2190.
13. Waltenberger J, Mayr U, Pentz S, Hombach V. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation. 94:1996;1647-1654.
14. Li J, Hampton T, Morgan JP, Simons M. Stretch-induced VEGF expression in the heart. J Clin Invest. 100:1997;18-24.
15. Weihrauch D, Tessmer J, Warltier DC, Chilian WM. Repetitive coronary artery occlusions induce release of growth factors into the myocardial interstitium. Am J Physiol Heart Circ Phy. 44:1998;H969-H976.
16. Brown LF, Berse B, Tognazzi K, Manseau EJ, van de Water L, Senger DR, Dvorak HF, Rosen S. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int. 42:1992;1457-1461.
17. Berse B, Brown LF, van de Water L, Dvorak HF, Senger DR. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell. 3:1992;211-220.
18. Möhle R, Green D, Moore MAS, Nachman RL, Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA. 94:1997;663-668.
19. Maloney JP, Silliman CC, Ambruso DR, Wang J, Tuder RM, Voelkel NF. In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol Heart Circ Phy. 44:1998;H1054-H1061.
20. Wartiovaara U, Salven P, Mikkola H, Lassila R, Kaukonen J, Joukov V, Orpana A, Ristimäki A, Heikinheimo M, Joensuu H, Alitalo K, Palotie A. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb Haemost. 80:1998;171-175.
21. Schultheiß HP, Tschoepe D, Schwippert B, Roesen P, Nieuwenhuis NK, Schmidt-Soltau C, Strauer B. Large platelets continue to circulate in an activated state after myocardial infarction. Eur J Clin Invest. 24:1994;243-247.
22. Gawaz M, Neumann FJ, Ott I, Schiessler A, Schömig A. Platelet function in acute myocardial infarction treated with angioplasty. Circulation. 93:1995;229-237.
23. Montrucchio G, Bergerone S, Alloatti G, Silvestro L, Lupia E, Cravetto A, Di Leo M, Emanuelli G, Camussi G. Streptokinase induces intravascular release of platelet-activating factor in patients with acute myocardial infarction and stimulates its synthesis by cultured human endothelial cells. Circulation. 88:1992;1476-1483.
24. Salgado R, Vermeulen PB, Benoy I, Weytjens R, Huget P, Van Marck E, Dirix LY. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients. Br J Cancer. 80:1999;892-897.
25. Verheul HMW, Hoekman K, Luykx-de Baker S, Eekman CA, Folman CC, Broxtermann HJ, Pinedo HM. Platelet: Transporter for Vascular Endothelial Growth Factor. Clin Cancer Res. 3:1997;2187-2190.
26. Neumann FJ, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M, Schömig A. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation. 92:1995;748-755.
27. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, DiPietro LA. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol. 152:1998;1445-1452.
28. Grad S, Ertel W, Keel M, Infanger M, Vonderschmitt DJ, Maly FE. Strongly enhanced serum levels of vascular endothelial growth factor (VEGF) after polyÍtrauma and burn. Clin Chem Lab Med. 36:1998;379-383.
29. Seko Y, Imai Y, Suzuki S, Kamijukkoku S, Hayasaki K, Sakomura Y, Tobe K, Kadowaki T, Maekawa H, Takahashi N, Yazaki Y. Serum levels of vascular endothelial growth factor in patients with acute myocardial infarction undergoing reperfusion therapy. Clin Sci. 92:1997;453-454.
30. Kawamoto A, Kawata H, Akai Y, Katsuyama Y, Takase E, Sasaki Y, Tsujimura S, Sakaguchi Y, Iwano M, Fujimoto S, Hashimoto T, Dohi K. Serum levels of VEGF and basic FGF in the subacute phase of myocardial infarction. Int J Cardiol. 67:1998;47-54.
31. Fujita M, Ikemoto M, Kishishita M, Otani H, Nohara R, Tanaka T, Tamaki S, Yamazato A, Saayama S. Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation. 4:1996;610-613.
32. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin C-H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem. 269:1994;26988-26995.
33. Kranz A, Mayr U, Frank H, Waltenberger J. The coronary endothelium: A target for VEGF. Human coronary artery endothelial cells express functional receptors for VEGF in vitro and in vivo. Lab Invest. 79:1999;985-991.
34. Habib GB, Heibig J, Formann SA, Brown BG, Roberts R, Terrin ML, Bolli R. Influence of coronary collateral vessels on myocardial infarct size in humans. Circulation. 83:1991;739-746.
35. Hirai T, Fujita M, Nakajima H, Asanoi H, Yamanishi K, Ohno A, Sasayama S. Importance of collateral circulation for prevention of left ventricular aneurysm formation in acute myocardial infarction. Circulation. 79:1989;791-796.
36. Marumo T, Schini-Kerth VB, Busse R. Vascular endothelial growth factor activates nuclear factor-kappa B and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes. 48:1999;1131-1137.
37. Lu M, Perez VL, Ma N, Miyamoto K, Peng HB, Liao JK, Adamis AP. VEGF increases retinal vascular ICAM-1 expression in vivo. Invest Ophthalmol Vis Sci. 40:1999;1808-1812.
38. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest. 101:1998;40-50.
39. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res. 80:1997;829-837.
40. Schaper W, Buschmann I. Collateral circulation and diabetes. Circulation. 99:1999;2224-2226.
41. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocrine Rev. 18:1997;4-25.